Phase I controlled trials of WR-2721 and cyclophosphamide.
about
Pre-treatment with amifostine protects against cyclophosphamide-induced disruption of taste in miceThe sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospectsStructural studies on the inactivation of gamma-glutamylcysteine synthetase by the disulphide analogues of radioprotective cysteamine derivatives. Effects of aminoalkyl and hydroxyalkyl chain length and beta beta-bis-dimethylation.
P2860
Phase I controlled trials of WR-2721 and cyclophosphamide.
description
1984 nî lūn-bûn
@nan
1984 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Phase I controlled trials of WR-2721 and cyclophosphamide.
@ast
Phase I controlled trials of WR-2721 and cyclophosphamide.
@en
type
label
Phase I controlled trials of WR-2721 and cyclophosphamide.
@ast
Phase I controlled trials of WR-2721 and cyclophosphamide.
@en
prefLabel
Phase I controlled trials of WR-2721 and cyclophosphamide.
@ast
Phase I controlled trials of WR-2721 and cyclophosphamide.
@en
P2093
P1476
Phase I controlled trials of WR-2721 and cyclophosphamide.
@en
P2093
P304
P407
P577
1984-09-01T00:00:00Z